Franco Muggia, M.D.
Barry Richter
Edward Ambinder, M.D.
Shirley Cox
Jaclyn Silverman
Edward Ambinder, M.D
Silvia Formenti, M.D.
Janice Gabrilove, M.D.
Howard Hochster, M.D.
Steven Itzkowitz, M.D.
Roman Perez-Soler, M.D
• Acute Leukemias
• Brain Cancer
• Breast Cancer
• Gastric Cancer
• Gynecological Cancers
• Hodgkin's Disease
• Lung Cancer
• Melanomas
• Non-Hodgkin's Lymphoma
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
The annual Symposium jointly sponsored by the Chemotherapy Foundation and the Mount Sinai School of Medicine presents New Developments in Cancer Therapeutics for Oncologists, Hematologists, Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers, and Pharmacists.
What Every Woman and Her Doctor Should Discuss about Ovarian Cancer
Ezra M. Greenspan, M.D., Franco Muggia, M.D.
Prostate Cancer: A Chronic Disease with Multiple Treatment Options
Anna C. Ferrari, M.D.
Chemotherapy Today: A Guide for Cancer Patients and Those Who Care About Them
Mary-Ellen Siegel, M.S.W., A.C.S.W, in collaboration with Franco M. Muggia, M.D.
Founder of The Chemotherapy Foundation, Clinical Professor of Medicine, Mount Sinai School of Medicine
Dr. Greenspan was a pioneering oncologist who founded The Chemotherapy Foundation in 1968 and its professional education arm, The chemotherapy Foundation Symposium in 1972, to bring the new developments in cancer therapeutics to practicing oncologists in the years ahead. His goal was the control and eventual cure of cancer. His early work is widely recognized as a forerunner to current progress in combating many types of cancer.
Chairman and Medical Director of The Chemotherapy Foundation
Director, Oncology Divsion, NYU Cancer Center
Dr. Muggia is a widely recognized expert and thought leader in clinical oncology who is responsible in collaboration with the Associate Medical Directors and the Scientific Advisory Council for selection of the research projects and investigators funded by The Chemotherapy Foundation. As Chairman of the Chemotherapy Foundation Symposium, Dr Muggia plays a major role in the annual professional education program.
President, The Chemotherapy Foundation
For over twenty years, Mr. Richter has devoted his efforts to expanding The Chemotherapy Foundation's programs and guiding its resources to fund the best scientists and clinical investigators to accelerate research initiatives that hold realistic promise for patient benefit in the near future, so that an ever increasing number of cancers can be managed and moved to the category of chronic diseases.
Director of Medical Symposia, The Chemotherapy Foundation Clinical Professor of Medicine and Oncologic Sciences, Mount Sinai School of Medicine
Dr. Ambinder, a recognized leader in oncology education, practice management and informatics, is responsible for new educational and informatic initiatives of the Foundation. He provides guidelines and oversight for the Program Review Committee of the Chemotherapy Foundation Symposium.